Open access · OA
via OpenAlex
Targeting Cellular Senescence for Healthy Aging: Advances in Senolytics and Senomorphics
Esther Ugo Alum, Sylvester Chibueze Izah, Daniel Ejim Uti, Okechukwu Paul-Chima Ugwu, Peter Aniah Betiang, Mariam Basajja, Regina Idu Ejemot-Nwadiaro
Drug Design Development and Therapy · 2025 · ▲ 27 citations
Cellular senescence
Chronic inflammation
Caloric restriction
Exercise
Senolytics
Human
Preclinical / animal
Review
Abstract
Background: Cellular senescence(definition) is a fundamental characteristic of aging, marked by permanent cell cycle cessation and the release of pro-inflammatory mediators. Although senescence plays advantageous roles in tissue regeneration and tumor suppression, its accumulation leads to aging-related illnesses and functional deterioration. Objective: This review examines the processes of cellular senescence, its effects on aging and age-related disorders, and emerging therapeutic strategies to modulate senescence for promoting healthy aging. Methods: A thorough literature review was performed using peer-reviewed studies on cellular senescence, its molecular pathways, and therapeutic interventions. Emphasis was placed on senolytics(definition), senomorphics, and lifestyle interventions that modulate senescence-associated pathways. Studies published in Scopus, Web of Science and PubMed between 2014-2025 were selected. Results: Recent discoveries underscore the dual function of cellular senescence in aging and pathology. The senescence-associated secretory phenotype (SASP) fosters chronic inflammation and tissue dysfunction, connecting senescence to age-related diseases including cardiovascular conditions, dementia, and metabolic disorders. Therapeutic strategies, including senolytics (drugs that specifically eradicate senescent cells) and senomorphics (compounds that suppress SASP without killing cells), show promise in preclinical and clinical studies. Notably, dosing interals (intermittent vs continuous) influence both therapeutic efficacy and adverse events such as thrombocytopenia. Additionally, the state and limitations of clinical validation of aging biomarkers (eg, p16^INK4a, β-galactosidase) remain major hurdles for translation. Lifestyle interventions such as calorie restriction and exercise have also been identified as natural modulators of senescence pathways. Conclusion: Targeting cellular senescence offers a promising avenue for promoting healthy aging and mitigating age-linked diseases. Continued research into senescence-modulating interventions may lead to novel therapeutics designed to prolong healthspan(definition) and lifespan.
◌ CITATION ONLY
Full text is not openly licensed for redistribution here. Read it at the source:
Provenance
- Source
- OpenAlex
- DOI
- 10.2147/dddt.s543211
- Canonical
- link ↗
- Fetched
- 2026-06-07 MST
Cite this
APA
Alum, E.U., Izah, S.C., Uti, D.E., Ugwu, O.P., Betiang, P.A., Basajja, M., & Ejemot-Nwadiaro, R.I. (2025). Targeting Cellular Senescence for Healthy Aging: Advances in Senolytics and Senomorphics. <em>Drug Design Development and Therapy</em>. https://doi.org/10.2147/dddt.s543211
Vancouver
Alum EU, Izah SC, Uti DE, Ugwu OP, Betiang PA, Basajja M, et al. Targeting Cellular Senescence for Healthy Aging: Advances in Senolytics and Senomorphics. Drug Design Development and Therapy. 2025. doi:10.2147/dddt.s543211.
BibTeX
@article{esther2025Target,
title = {Targeting Cellular Senescence for Healthy Aging: Advances in Senolytics and Senomorphics},
author = {Esther Ugo Alum and Sylvester Chibueze Izah and Daniel Ejim Uti and Okechukwu Paul-Chima Ugwu and Peter Aniah Betiang and Mariam Basajja and Regina Idu Ejemot-Nwadiaro},
journal = {Drug Design Development and Therapy},
year = {2025},
doi = {10.2147/dddt.s543211},
}
Research neighborhood
References, citing works, and semantically nearest findings. Click a node to open it.
Related findings
Drug design, development and therapy 2025
Open access · OA
Targeting Cellular Senescence for Healthy Aging: Advances in Senolytics and Senomorphics.
Frontiers in Pharmacology 2025
Open access · CC-BY
Recent advances in dermal fibroblast senescence and skin aging: unraveling mechanisms and pioneering therapeutic strategies
Therapeutic Advances in Chronic Disease 2020
Open access · CC-BY
Advancements in therapeutic drugs targeting of senescence
Biomolecules 2025
Open access · CC-BY
Targeting Senescence: A Review of Senolytics and Senomorphics in Anti-Aging Interventions
Signal Transduction and Targeted Therapy 2026
Open access · CC-BY
Insights into the therapeutic strategies for aging and aging-associated diseases
Korean journal of family medicine 2025
Open access · OA